Qizhe tumor embryonic protein in vitro reagent group - Taiwan Registration a13b98752387caf3d84638b04a7c8f5f

Access comprehensive regulatory information for Qizhe tumor embryonic protein in vitro reagent group in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number a13b98752387caf3d84638b04a7c8f5f and manufactured by Longteng Biotechnology Co., Ltd. The authorized representative in Taiwan is Qizhe Biotechnology Co., Ltd.

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.